Trailing Twelve Months Financial ResultsFor the trailing twelve months ended June 30, 2011, Adjusted EBITDA was $57.4 million and Adjusted EBITDA before restructuring and other charges was $57.2 million.
For the trailing twelve months ended June 30, 2011, GAAP net income was $24.6 million, or $1.89 per share (diluted) and non-GAAP adjusted net income (before restructuring and other charges, stock compensation expense, and loss on extinguishment of debt) was $25.9 million, or $1.98 per share (diluted).
Click here to read more details:
Destination Maternity Corporation
marketing@alchempro.com
